David T. Lynch, PhD, recently joined Koneksa as CEO and member of the Board of Directors. Dr. Lynch brings over 20 years of experience in corporate strategy, business development and a record of transformational leadership.

 

Most recently, Dr. Lynch served as CEO of Strateos, a first of its kind, fully automated, robotic cloud laboratory platform- helping drive digital transformation and automating drug discovery across the biopharma industry. During his tenure as CEO, he devised a high-impact turnaround strategy to refocus the product strategy and commercial model resulting in a step change for the business that culminated in a successful exit.

 

Prior to that, Dr. Lynch held senior commercial leadership roles to drive accelerated growth for life science tools, software and clinical service companies. Dr. Lynch holds a B.Sc. in Biology from Syracuse University and a PhD in Microbiology and Infectious Diseases from the University of Pittsburgh School of Public Health.